BioNano Genomics, Inc (43)

Browse by Contract Category

Contracts

Fifth Amendment to the Lease by and between the Registrant and The Irvine Company, LLC, dated January 12, 2022 (Filed With SEC on March 1, 2022)
Employment Agreement, dated June 14, 2021, by and between the Company and Richard Shippy (Filed With SEC on March 1, 2022)
Stock Restriction Agreement (Filed With SEC on March 1, 2022)
Agreement and Plan of Merger, dated October 8, 2021, by and among the Company, Starship Merger Sub I, Inc., Starship Merger Sub II, LLC, BioDiscovery, Inc. and Soheil Shams (Filed With SEC on October 19, 2021)
Bionano Genomics, Inc. 2020 Inducement Plan dated August 20, 2020, as amended (Filed With SEC on October 12, 2021)
Sales Agreement, dated March 23, 2021, by and between the Company and Cowen and Company, LLC (Filed With SEC on March 24, 2021)
Commercial Single-Tenant Lease Net, dated February 28, 2016, by and between Tesa Beach LLC and BioDiscovery, Inc (Filed With SEC on March 1, 2022)
Employment Agreement (Filed With SEC on March 1, 2022)
Standard Industrial/Commercial Single-Tenant Lease, made effective as of November 23, 2021, by and between the Company and 6777 Nancy Ridge LLC (Filed With SEC on March 1, 2022)
Bionano Genomics, Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 1, 2022)
Non-Employee Director Compensation Policy, as Amended (Filed With SEC on November 4, 2021)
Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Bionano Genomics, Inc. 2018 Equity Incentive Plan (Filed With SEC on August 4, 2021)
Fourth Amendment to Loan and Security Agreement, dated December 30, 2020, by and among the Company, Lineagen, Inc., Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on March 23, 2021)
Fourth Amendment to the Lease by and between the Registrant and The Irvine Company LLC, dated February 15, 2021 (Filed With SEC on March 23, 2021)
Third Amendment to the Lease by and between the Registrant and The Irvine Company LLC, dated December 19, 2019 (Filed With SEC on March 23, 2021)
Description of the Companys Securities (Filed With SEC on March 23, 2021)
Underwriting Agreement, dated January 20, 2021, by and among Bionano Genomics, Inc. and Oppenheimer & Co. Inc., as representatives of the several underwriters named therein (Filed With SEC on January 21, 2021)
Underwriting Agreement, dated January 8, 2021, by and among Bionano Genomics, Inc. and Oppenheimer & Co. Inc., as representatives of the several underwriters named therein (Filed With SEC on January 11, 2021)
Agreement and Plan of Merger, dated August 21, 2020, by and among the Company, Alta Merger Sub, Inc., Lineagen, Inc. and Michael S. Paul, Ph.D (Filed With SEC on November 13, 2020)
Employment Agreement, effective as of August 31, 2020, by and between Alka Chaubey and the Company (Filed With SEC on November 13, 2020)
Employment Agreement, effective as of September 1, 2020, by and between Christopher Stewart and the Company (Filed With SEC on November 13, 2020)
Consent and Third Amendment to Loan and Security Agreement, dated August 21, 2020, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on November 13, 2020)
Form of Stock Option Grant Notice and Stock Option Agreement under the Bionano Genomics, Inc. 2020 Inducement Plan (Filed With SEC on August 24, 2020)
Bionano Genomics, Inc. 2020 Inducement Plan (Filed With SEC on August 24, 2020)
Description of the Company's Securities (Filed With SEC on August 13, 2020)
Form of Pre-Funded Warrant (Filed With SEC on March 24, 2020)
Form of Warrant to Purchase Common Stock (Filed With SEC on March 24, 2020)
Form of Underwriting Agreement (Filed With SEC on March 24, 2020)
Second Amendment to Loan Agreement, dated March 6, 2020, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on March 10, 2020)
Description of the Companys Securities (Filed With SEC on March 10, 2020)
Form of New Warrant (Filed With SEC on March 2, 2020)
Form of Warrants Amendment and Agreement (Filed With SEC on March 2, 2020)
Form of Pre-Funded Warrant (Filed With SEC on October 17, 2019)
Form of Underwriting Agreement (Filed With SEC on October 17, 2019)
Form of Warrant to Purchase Common Stock (Filed With SEC on September 18, 2019)
Form of Underwriting Agreement (Filed With SEC on September 18, 2019)
Waiver and First Amendment to Loan and Security Agreement, dated June 25, 2019, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on August 8, 2019)
Common Stock Purchase Agreement, dated March 14, 2019, between the Company and Aspire Capital Fund, LLC (Filed With SEC on March 14, 2019)
Registration Rights Agreement, dated March 14, 2019, by and among the Company and the Innovatus Investors (Filed With SEC on March 14, 2019)
Form of Warrant to Purchase Common Stock for Innovatus (Filed With SEC on March 14, 2019)
Common Stock Purchase Agreement, dated March 14, 2019, by and among the Company and the Innovatus Investors (Filed With SEC on March 14, 2019)
Loan and Security Agreement, dated March 14, 2019, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and the Lenders listed on Schedule 1.1 thereto (Filed With SEC on March 14, 2019)
Registration Rights Agreement, dated March 14, 2019, between the Company and Aspire Capital Fund, LLC (Filed With SEC on March 14, 2019)